Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Completed 77Unknown 39Recruiting 17Terminated 15Active not recruiting 11Withdrawn 1Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Myasthenia Gravis 2Leukemia, Myeloid, Acute 2Radiodermatitis 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Gallbladder Neoplasms 1Fibrosis 1Esophageal Squamous Cell Carcinoma 1Depression 1Cognitive Dysfunction 1Chemotherapy-Related Cognitive Impairment 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1Breast Neoplasms 1Breast Cancer Metastatic 1

Interventions

R-CHOP protocol 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Enrolling by invitation × Lymphoma, Large B-Cell, Diffuse × Clear all
NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Second Affiliated Hospital of Nanchang University

Phase 3 Enrolling by invitation
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡